Aptar Pharma Enters Collaboration with CHI for Quattrii DPI Platform
Aptar Pharma has announced an exclusive collaboration with Cambridge Healthcare Innovations (CHI) to lead the commercialisation of the Quattrii Dry Powder Inhaler (DPI) platform. Through this agreement, Aptar Pharma will serve as the primary contact for customers and prepare the